STERIS plc (STE)
NYSE: STE · Real-Time Price · USD
214.34
-1.43 (-0.66%)
Nov 22, 2024, 4:00 PM EST - Market closed
STERIS Revenue
STERIS had revenue of $1.33B in the quarter ending September 30, 2024, with 7.33% growth. This brings the company's revenue in the last twelve months to $5.33B, up 15.75% year-over-year. In the fiscal year ending March 31, 2024, STERIS had annual revenue of $5.14B with 13.28% growth.
Revenue (ttm)
$5.33B
Revenue Growth
+15.75%
P/S Ratio
3.98
Revenue / Employee
$292,949
Employees
18,179
Market Cap
21.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 5.14B | 602.44M | 13.28% |
| Mar 31, 2023 | 4.54B | 312.86M | 7.41% |
| Mar 31, 2022 | 4.22B | 1.12B | 35.91% |
| Mar 31, 2021 | 3.11B | 76.62M | 2.53% |
| Mar 31, 2020 | 3.03B | 248.73M | 8.94% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical | 16.77B |
| Labcorp Holdings | 12.71B |
| Biogen | 9.61B |
| Zimmer Biomet Holdings | 7.60B |
| Illumina | 4.39B |
| The Cooper Companies | 3.80B |
| BeiGene | 3.35B |
| Waters | 2.91B |
STE News
- 5 days ago - Steris Q2: Anticipating HSD Growth In AST, Upgrade To 'Buy' - Seeking Alpha
- 15 days ago - STERIS plc (STE) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 16 days ago - Steris beats quarterly estimates on continued demand for medical procedures - Reuters
- 16 days ago - STERIS Announces Financial Results for Fiscal 2025 Second Quarter - GlobeNewsWire
- 23 days ago - STERIS Declares Dividend of $0.57 per share - GlobeNewsWire
- 4 weeks ago - STERIS to Host a Conference Call for Fiscal 2025 Second Quarter Financial Results on November 7, 2024 - GlobeNewsWire
- 6 weeks ago - STERIS plc (STE) Enters New $1.1 Billion Revolving Credit Agreement - GuruFocus
- 3 months ago - 15 Upcoming Dividend Increases Including A King - Seeking Alpha